Skip to content

Biogen BIIB Total costs & expenses

Total costs & expenses at other companies

Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
Royalty Pharma logo
Royalty PharmaRPRX
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
Amgen logo
AmgenAMGN
Incyte logo
IncyteINCY
Gilead Sciences logo
Gilead SciencesGILD

Other financials

Income statement

See full
Revenue$2.5B+1.9%
Gross profit$1.8B+0.8%
Net income$319.5M+32.9%
EPS (diluted)$2.15+31.1%

Balance sheet

See full
Cash & equivalents$3.4B+30.2%
Total debt$6.6B+34.7%
Total equity$18.7B+9.9%
Total assets$29.5B+5.2%

Cash flow

See full
Operating cash flow$645.5M+149%
CapEx$51.2M+38.0%
Free cash flow$594.3M+167%

Valuation

See full
Market cap$29.33B+34.3%
Enterprise value$32.51B+34.9%
P/E20.6×+5.9×
P/S+0.7×

Profitability

See full
Gross margin75.5%-0.1pp
Operating margin22.9%
Net margin14.3%-0.8pp

Returns & leverage

See full
Return on equity8%-1.2pp
Debt / equity0.4×+0.1×
Current ratio3.1×+1.6×

Where this comes from

Reported directly by Biogen in its filing.

Tagged under the XBRL concept us-gaap:CostsAndExpenses.

The official record: Biogen’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biogen's total costs & expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biogen's total costs & expenses?
Biogen (BIIB) reported total costs & expenses of $2.1B in Q1 2026.
How has Biogen's total costs & expenses changed year-over-year?
Biogen's total costs & expenses decreased by 0.9% year-over-year, from $2.12B to $2.1B.
What is the long-term trend for Biogen's total costs & expenses?
Over 4 years (2021 to 2025), Biogen's total costs & expenses has grown at a -1.2% compound annual growth rate (CAGR), from $8.73B to $8.33B.